Biocryst Pharmaceuticals Inc (BCRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BCRX? Forum Prognose

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.24% 163.35	145.53	131.53	117.08	109.33
Cost Of Revenue	38.75% 2.798	4.568	6.094	3.211	1.699
Gross Profit	13.90% 160.56	140.97	125.44	113.87	107.63
Operating Expenses	9.21% 130.77	119.74	129.95	106.18	98.87
Benefits Costs and Expenses	8.35% 156.87	144.78	157.53	130.53	121.83
Costs And Expenses	7.45% 133.57	124.31	136.04	109.39	100.57
Operating Income/Loss	40.32% 29.79	21.23	-4.508	7.692	8.761
Nonoperating Income/Loss	13.83% -23.30	-20.47	-	-	-
Income/Loss From Continuing Operations Before Tax	755.67% 6.486	0.758	-25.99	-13.45	-12.50
Income Tax Expense/Benefit	92.98% 1.401	0.726	0.804	0.586	0.172
Income/Loss From Continuing Operations After Tax	15,791% 5.085	0.032	-26.80	-14.03	-12.67
Net Income/Loss	15,791% 5.085	0.032	-26.80	-14.03	-12.67
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.30% 209.52	208.88	0.23	206.91	206.43
Diluted Average Shares	2.15% 219.89	215.26	0.23	206.91	206.43
Basic Earnings Per Share	0.02	-	-0.13	-0.07	-0.06
Diluted Earnings Per Share	0.02	-	-0.13	-0.07	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

HIMS

$44.39

2.35%

RDY

$13.41

0.90%

ELAN

$22.85

3.16%

VTRS

$10.53

1.64%

NBIX

$141.96

0.87%

UTHR

$438.66

1.52%